LoginRegister
    Novartis gene therapy could get FDA approval in MayNovartis gene therapy could get FDA approval in May
    Argenx and J&J subsidiary signs a deal to develop CusatuzumabArgenx and J&J subsidiary signs a deal to develop Cusatuzumab
    Ultimovacs plans to raise $82 million in IPO to develop cancer drugUltimovacs plans to raise $82 million in IPO to develop cancer drug
    Chairman Anders Lonner dead: Karo PharmaChairman Anders Lonner dead: Karo Pharma
    With Gluten or Gluten Free : Drugmakers will soon have to likely declare on labelling the presence of GlutenWith Gluten or Gluten Free : Drugmakers will soon have to likely declare on labelling the presence...
    Sun Pharma gets USFDA nod for Ganirelix Acetate injectionSun Pharma gets USFDA nod for Ganirelix Acetate injection
    USFDA approval to Zydus to market Teriflunomide tablets for MS relapseUSFDA approval to Zydus to market Teriflunomide tablets for MS relapse
    Gilead cell therapy Yescarta proves durable for some lymphoma patientsGilead cell therapy Yescarta proves durable for some lymphoma patients
    Lupin launches Nystatin and Triamcinolone Acetonide in the US marketLupin launches Nystatin and Triamcinolone Acetonide in the US market
    Regulations on Biotech sector must ease further: Biocon ChiefRegulations on Biotech sector must ease further: Biocon Chief
    Launch of User Manual on SUGAM portal: CDSCOLaunch of User Manual on SUGAM portal: CDSCO
    FDA nods to Truxima-first biosimilar to Roche cancer drug RituxanFDA nods to Truxima-first biosimilar to Roche cancer drug Rituxan
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X